Immunomodulators
JP7873405B2Active Publication Date: 2026-06-12ELYSIUM SCI CO LTD +1
Patent Information
- Application Number
- JP2022071306
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2022-04-25
- Publication Date
- 2026-06-12
- Estimated Expiration
- 2042-04-25
AI Technical Summary
Benefits of technology
【0015】 この発明によれば、免疫の異常に起因する疾患に効能を有する。
✦ Generated by Eureka AI based on patent content.
Smart Images
Figure 0007873405000001 
Figure 0007873405000002
Abstract
To provide an immunoregulator that is effective in treating disease caused by immune disorder.SOLUTION: An immunoregulator contains chondroitin sulfate, unsaturated fatty acid, vitamin B and vitamin D and has a regulating effect to normalize immune disorder.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art
Claims
1. An immunomodulator containing chondroitin sulfate, oleic acid, vitamin B, and vitamin D, which adjusts the immune system to normalize abnormalities.
2. The aforementioned vitamin B is, Vitamin B ６ and Vitamin B １２ The immunomodulator according to claim 1.
3. The aforementioned chondroitin sulfate is The immunomodulator according to claim 1 or 2, wherein the immunomodulator is chondroitin sulfate A and chondroitin sulfate C.
4. The immunomodulator according to claim 3, wherein the chondroitin sulfate C is derived from the cartilage of marine organisms.
Citation Information
Patent Citations
Heterogeneous molecular lipid(CHML)of affinity to cell and manufacture thereof
JP1990262514A
Usage of vegetable oils
JP1997502196A
Compositions and methods for prevention and treatment of vascular degenerative diseases
JP2001511153A
Pharmaceutical composition containing lactoferrin and method for producing processed food containing lactoferrin
JP2005068060A
Antiinflammatory agent containing monomer macrophage migration inhibitory factor (MIF)
JP2011201875A